Jubilant Pharmova Appoints Arun Kumar Sharma as Interim CFO
Jubilant Pharmova has Arun Kumar Sharma as Chief Financial Officer (CFO) and Key Managerial Personnel (KMP) of the company for an interim period, effective October 1, 2025. He will serve in this role until the appointment of a new CFO is finalised.
Chief Financial Officer | 23/09/2025 | By Dineshwori
Alkermes appoints Joshua Reed as CFO
The newly-appointed CFO at Alkermes, Joshua Reed, brings over 30 years of financial leadership experience, with a strong focus in the biotechnology and pharmaceutical sectors. Most recently, he served as CFO of Omega Therapeutics.
Chief Financial Officer | 13/09/2025 | By Dineshwori
Alembic Pharma Appoints Former Syngene VP G Krishnan as New CFO
G Krishnan has taken over as the new Chief Financial Officer (CFO) of Alembic Pharmaceuticals, succeeding R. K. Baheti.
Chief Financial Officer | 08/07/2025 | By Manvi | 349
Karyopharm Welcomes Lori Macomber as its New Chief Financial Officer
Macomber has over 20 years of diversified experience in leading growth and driving financial strategies for life science companies.
Chief Financial Officer | 03/01/2025 | By Aishwarya | 226
NRx Pharmaceuticals Welcomes Michael Abrams as Chief Financial Officer
Abrams succeeds Interim-CFO Richard Narido, who will continue to support the Company's financial function and other projects.
Chief Financial Officer | 19/11/2024 | By Aishwarya | 263
CureVac Welcomes Axel Sven Malkomes as New Chief Financial Officer
Malkomes joins CureVac at a pivotal moment as the company enters a new chapter of growth and innovation, bringing over three decades of senior corporate and investment banking experience within the biotech and pharmaceutical industries.
Chief Financial Officer | 05/11/2024 | By Aishwarya | 309
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy